Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I LOVE NTEK!!! What penny company provides a channel just for their investors to provide them information? None that I know of. Holding Long and Strong!!
Holding and accumulating here!! I dont care what the pps is currently or in the near term. Long sighted here! Future= $$$
From Yahoo! Finance site: finance.yahoo.com/news/nanotech-entertainment-ntek-announces-manager-151100658.html
SAN JOSE, Calif., April 25, 2013 /PRNewswire/ -- NANOTECH ENTERTAINMENT (NTEK) today announced the appointment of Lorraine Cullivan as NanoTech's Manager of Investor Relations. Mrs. Cullivan brings direct investment industry experience to her new role having previously served with companies including Putnam Investments.
"We are excited to have the opportunity to have Lorraine bring her investment industry knowledge and experience to the NanoTech management team," said Jeffrey A. Foley, NanoTech CEO. "In her new role she will be responsible for overseeing all of our investor questions and support. As NanoTech grows and expands, this is a crucial role for our investors to gain insight and information. We look to support of investor due diligence and research while continuing our commitment to transparency. Lorraine's experience in the investment industry adds value to NanoTech management." Foley continued, "Given that we executing our business plan and are accelerating our growth strategy, including generating substantial revenues and shipping product worldwide, we anticipate more investors coming to NanoTech. We want to be ready to handle the flow of information for all of our investors, both individual and corporate."
Mrs. Cullivan is taking over IR responsibilities form Denise Clifford, who will be moving to a Public Relations position within the company. All investor inquiries may be addressed to ir@nanotechent.com.
About NanoTech Entertainment
Headquartered in San Jose, CA, with US operations in NV, MA, along with India and China, NanoTech Entertainment is a global technology company that focuses on all aspects of the entertainment industry. With three business units, focusing on Gaming, Media & IPTV and Mobile Apps, the company has a unique business model. The company has a diverse portfolio of products and technology. NanoTech Gaming Labs operates as a virtual manufacturer, developing its technology and games, and licensing them to third parties for manufacturing and distribution in order to keep its overhead extremely low and operations efficient in the new global manufacturing economy. NanoTech Media develops proprietary technology which it licenses to publishers for use in their products as well as creating and publishing unique content. NanoTech Communications develops and sells proprietary apps and technology in the Mobile and Consumer space. NanoTech is redefining the role of developers and manufacturers in the global market. More information about NanoTech Entertainment and its products can be found on the web at www.NanoTechEnt.com.
NanoTech Entertainment (NTEK) trades on OTC Pink, the open marketplace for a wide spectrum of equity securities. Investors can find real-time quotes and market information at www.otcmarkets.com.
"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results.
The NanoTech Entertainment logo is a trademark of NanoTech Entertainment, Inc. All rights reserved. All other marks are the property of their respective owners. "The Future of Television" is a service mark of NanoTech Entertainment, Inc., All Rights Reserved
Contact: Denise Clifford
Phone: (408) 414-7355
Email: pr@nanotechent.com
I like the fact that there creating various channels that appeal to a wide array of people. From young clubbing youth to parents with children. More potential purchasers = $$$
At the bottom of that article in the Sac Bee it says the following which I really liked
"The NanoTech Entertainment logo is a trademark of NanoTech Entertainment, Inc. All rights reserved. All other marks are the property of their respective owners. "The Future of Television" is a service mark of NanoTech Entertainment, Inc., All Rights Reserved"
Read more here: http://www.sacbee.com/2013/04/19/5355618/nanotech-entertainment-ntek-annouces.html#storylink=cpy
NTEK= $$$. Long and Strong. Like I continue to say "Dont care what happens today or tomorrow...." Looking forward to the future and patience will reward us longs.
Smart man Mexico!! I have made 3 seperate purchases of NTEK along the way myself. Accumulating and holding.
LONG and STRONG. Dont care if this goes all the way down to .00001 today or tomorrow. In the long term, this will be golden. If you are impatient, this isnt the one for you.
No fear here. Long and Strong! Accumulating and holding as I know whats in store for us if we can just sit tight and be patient. I know what I hold....
Looks like the dolphins are playing this and flipping it back down some. Perfect time to get some more cheapies.....
This is nothing! BUY and HOLD people. NTEK is a long play and will make lots of $$$ for those who are patient. Things are only going to get alot better.
These are real CHEAP people! This wont last for too long and you better get in before its too late. NTEK= $$$
In my honest opinion within the next several months even $0.10 will be cheap! LONG and STRONG and enjoying this ride...
STKO and BMSN not looking good huh NTEK Haters? You sure know how to pick em
Honestly, anything under $0.10 is going to be a real bargain within the next several months imo. Do your homework(DD) and you will know why too. Long and Strong NTEK'er
LONG and STRONG. Not here to flip this and just monitoring here and there thru out the day because this is one in a million thats transparent and provides lots of updates to its shareholders.
From last week on Yahoo Finance. It might be old but good news for those that are long imo: finance.yahoo.com/news/bio-matrix-scientific-groups-regen-200500215.html
SAN DIEGO, CA--(Marketwired - Apr 4, 2013) - Regen BioPharma, Inc. (Regen), a wholly-owned subsidiary of Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN), provided an update on the Company's progress with HemaXellerate and other new developments.
Currently, Regen is focused on two core areas: a)The HemaXellerate Program, which is based on treating disorders of blood production; and b) Our cancer immunotherapy Program which leverages specific cells called "dendritic cells" to specifically kill cancer but not healthy tissue.
In June 2012 the Company acquired an option to license US patent # 6,821,513 covering use of endothelial cells to stimulate blood cell production. Subsequently Regen has filed patent applications # 61/648898 and # 61/670791 covering stimulation of blood cell production using placental and fat derived cells, respectively.
Utilizing these technologies, as well as, results obtained from studies performed at the Torrey Pines Institute for Molecular Medicine by Sophia Khaldoyanidi, M.D., Ph.D., Regen has developed the HemaXellerate product, which is a patient-specific composition of cells that has previously been demonstrated to repair damaged bone marrow and stimulate production of blood cells.
Together with opinion leaders from University of Utah, Indiana University, and Cook General Biotechnology, Regen has published a peer-reviewed paper describing preclinical data supporting the use of HemaXellerate http://www.translational-medicine.com/content/pdf/1479-5876-10-231.pdf. This paper was widely received by the scientific community and was granted "Highly Accessed" status by the Journal of Translational Medicine.
On February 5th, 2013 Regen filed an Investigational New Drug (IND) application with the FDA to initiate clinical trials using HemaXellerate for treatment of patients with aplastic anemia that are resistant to current therapies. The FDA issued IND # 15376 to Regen in response to the Company's IND application. The Company has been in communication with the FDA, which informed us that, as per FDA procedure, a letter outlining items which must be addressed prior to initiating clinical trials will be sent to us shortly. Regen is confident the Company will be able to address these items to the FDA's satisfaction. It is the goal of the Company to initiate clinical trials by Q4 of 2013. Additionally, aplastic anemia is considered an Orphan Disease and we plan to apply for Orphan Drug Status during clinical development.
Proof of concept in the proposed 10 patient aplastic anemia trial will allow us to expand into the larger market of blood production disorders which exceeds $4.84 billion per year and currently addressed by growth factors such as Neupogen®, Neulasta®, Leukine® and Revolade®. (www.wikinvest.com/stock/Amgen). The clinical trial is anticipated to take 12-18 months until completion and the Principle Investigator is Dr. Michael Murphy from Indiana University who previously published with us. Regen plans to execute a licensing/co-development agreement once proof of concept in patients has been obtained.
The second program is based on a patent portfolio, including patent # 8,389,708 for which Regen has signed a Letter of Intent for licensing from Professor Wei-Ping Min from the University of Western Ontario. To date approximately 1.5 million dollars has been spent on development of the technology. Published research by Professor Min demonstrates effective killing of tumor cells without side effects in mice models of melanoma (Zheng et al. J Immunol. 2006 Oct 15;177(8):5639-46) and breast cancer (Zheng et al. Int J Cancer. 2013 Feb 15;132(4):967-77).
We plan to in-license the patent portfolio in Q2 of 2013 and establish collaborations with academic and industry groups to file an IND by Q4 of 2013. The first indication we will be pursuing will be therapy-resistant metastatic breast cancer. There are 209,995 new cases of breast cancer per year, of which 30% are treatment resistant(1). Herceptin, which induces therapeutic effects in only 25% of patients with metastatic breast cancer, had sales of $1.1 billion in 2011(2). The clinical trial is anticipated to be a Phase I/II proof of concept trial which will take 12-18 months to complete. As with the HemaXellarate Program, we anticipate licensing/co-development once clinical proof of concept is achieved.
Below is a summary of our milestones achieved and upcoming projections:
Milestones Achieved
HemaXellarate product developed
Preclinical data published
Principle Investigator recruited
FDA # granted
Second program conceptualized, discussions ongoing for licensing
Upcoming Milestones
Response to FDA questions: Q3 2013
Initiate HemaXellerate trial: Q4 2013
Complete HemaXellerate trial: Q4 2014-Q2 2015
In license Min technology: Q2 2013
File IND on Min technology: Q4 2013
Initiate clinical trial on Min technology: Q4 2013
Complete clinical trial on Min technology: Q4 2014-Q2 2015
About Bio-Matrix Scientific Group, Inc. and Regen BioPharma, Inc.:
Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) through its wholly owned subsidiary, Regen BioPharma, Inc., is a biotechnology company focused on identifying undervalued regenerative medicine patents in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/II clinical trials. To follow our development, visit us at www.regenbiopharma.com.
Disclaimer
This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Not me. Buying and holding! I know what NTEK is and I cant be scared away like some.
There selling because they do not know what NTEK is! I am sooo happy right now as I got filled at these cheapies!!! Go NTEK !!
Dolphins flipping in the NTEK ocean right now....Long and Strong here!!
I see a NTEK Hater back at it again.... Im not selling my shares! This here people is really cheap and wont last too long.
Where are the Haters now? Mad that this green huh? Go NTEK! Long and STRONG!!!
RSI and SLO STO signaling a pretty strong reversal. Its also looking like the dolphins are in effect here with sells at this moment
There not getting my shares! I dont care if it dropped 1000%. I know what I got! Our time will come
I LOVE NTEK!! What a great company and leadership! I havent been apart of one like this before! LONG and STRONG! Dont care about today or tomorrow.
Man, I wish I could go to the Share Holders Meeting!! I could only imagine the new projects, revenues, projections, etc.... Cha-Ching $$$
Chart seems to be signaling a reversal? STO and RSI indicate over-sold and time to go north. Last time it was this low was in early January
LONG and STRONG here! Dont care what happens today or this week.... I know whats going to happen in the near future. WEEEEEE.....
Not giving up my shares! I have done enough DD to understand whats at stake here. I love to gamble and can be patient. I am not in here to flip like a dolphin but good luck to those that are! Get your $$$
WOW! Man, I can only imagine what the revenue projections for end of year are going to be.... $$$ LONG and STRONG here!
Better than not tweeting anything at all and people complaining that no one from NTEK communicates in any way with the investors. You can call it fluff but to me its communication.
Wow, thanks for the pics of the new building\office in San Jose! Nice to see a real office and hear from real employees, etc... NTEK Long and Strong here!! Its very rare that a penny stock company shares as much information about itself as NTEK does.
And I would imagine that will be in a BestBuy and WalMart too in the near future Niko. $$$$ I LOVE NTEK!
LONG and STRONG here. Cant have my shares! This is the perfect one for the dolphins tho!
Slo STO at 8.9, very low and turning north! Time to BUY!! LONG and STRONG here!! They cant get my shares. Dolphin time
not giving up my shares! Fearless!!
LONG and STRONG! Patience will be rewarded. I know what I own.
LONG and STRONG!! Dont care what happens today or tomorrow.... This will take time. Im patient for the BIG $$$
Do your own DD and make your own decision based on that information. I did and holding LONG and STRONG.
LONG and STRONG here! Dolphins should head north and allow the whales to wait it out here. I know what I got and not lookin at this as a daily trader but good luck to those who are.
I think next month in the company meeting they will provide us with more detailed information.... Patience young grasshoppa.